A recent meta-analysis of mixed evidence (5 RCTs 52,183,184,185,186 and 1 cohort study 187 ) in 2,071 people with T2DM or Parkinsons disease suggested antidepressant efficacy of the GLP-1RAs exenatide and liraglutide over 2452 weeks 188
Acknowledgements This article is distributed under the terms of the Creative Commons Attribution Non-Commercial 4.0 International License ( which permits any non-commercial use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made
PMID: 38858523 | doi:10.1038/s41591-024-03018-2 Pasqualotto E et al
No path to weight loss is complete without an understanding of your body's nutrient needs and how best to meet them
Population differences between trials also deserve consideration
doi: 10.1371/journal.pone.0289616